Fransen, Signe <br/><br/>
Longitudinal analysis of raltegravir susceptibility and integrase replication capacity of human immunodeficiency virus type 1 during virologic failure.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Oct 2009 
 - 4522-4 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.00651-09  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Line<br/>Drug Resistance, Viral--genetics<br/>HIV Integrase Inhibitors--pharmacology<br/>HIV-1--drug effects<br/>Humans<br/>Pyrrolidinones--pharmacology<br/>Raltegravir Potassium<br/>Virus Replication--drug effects